Stay updated on Pembrolizumab for Rare Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Rare Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Paraganglioma added to conditions; page revision updated to v3.5.0, replacing v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T21:00:25.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T19:49:36.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page.
    Difference
    0.0%
    Check dated 2026-02-12T01:53:57.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    New study record dates were added (2026-01-12, 2026-01-29, 2026-01, 2028-12-31). Old dates (2025-07-31, 2025-12-31, 2025-07-29, 2025-07) were removed and the revision tag updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T23:38:02.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Glossary toggle added and a new 'Revision: v3.4.0' label appears alongside 'Last Update Submitted that Met QC Criteria'. The previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.
    Difference
    0.2%
    Check dated 2026-01-28T21:15:46.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. This appears to be a minor metadata update with no visible content changes.
    Difference
    0.0%
    Check dated 2026-01-14T04:12:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Rare Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.